Donepezil, Rivastigmine and Galantamine: Cholinesterase Inhibitors for Alzheimer's Disease
Subas M. Sakya, Kapil Karki
Abstract
Subas M. Sakya, Kapil Karki
Abstract
This chapter contains sections titled: Background Pharmacology Structure–Activity Relationship (SAR) Pharmacokinetics and Drug Metabolism Efficacy and Safety Syntheses of Donepezil Syntheses of Rivastigmine Syntheses of Galantamine
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter contains sections titled: Background Pharmacology Structure–Activity Relationship (SAR) Pharmacokinetics and Drug Metabolism Efficacy and Safety Syntheses of Donepezil Syntheses of Rivastigmine Syntheses of Galantamine
Key concepts: Rivastigmine, Donepezil, Galantamine, Cholinesterase, Pharmacology, Medicine, Acetylcholinesterase, Drug